The Australian market is currently experiencing a positive shift, with shares advancing on the news of a potential peace agreement between Iran and the U.S., which has traders optimistic about stability in global oil flows. In this environment, identifying undervalued stocks can be particularly rewarding as investors seek opportunities that are priced below their intrinsic value, such as Capricorn Metals and two other promising picks.
Top 10 Undervalued Stocks Based On Cash Flows In Australia
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Nuix (ASX:NXL) |
A$1.385 |
A$2.52 |
45% |
| NRW Holdings (ASX:NWH) |
A$7.25 |
A$12.63 |
42.6% |
| Magellan Financial Group (ASX:MFG) |
A$9.55 |
A$17.21 |
44.5% |
| Lycopodium (ASX:LYL) |
A$16.59 |
A$28.63 |
42.1% |
| Lovisa Holdings (ASX:LOV) |
A$22.76 |
A$43.14 |
47.2% |
| Kogan.com (ASX:KGN) |
A$4.27 |
A$7.22 |
40.9% |
| Judo Capital Holdings (ASX:JDO) |
A$1.49 |
A$2.52 |
40.9% |
| Integral Diagnostics (ASX:IDX) |
A$2.07 |
A$4.13 |
49.9% |
| Frontier Digital Ventures (ASX:FDV) |
A$0.32 |
A$0.58 |
44.4% |
| Capricorn Metals (ASX:CMM) |
A$13.36 |
A$25.73 |
48.1% |
Underneath we present a selection of stocks filtered out by our screen.
Capricorn Metals
Overview:Capricorn Metals Ltd, with a market cap of A$6.10 billion, is engaged in the exploration, development, evaluation, and production of gold in Australia.
Operations:The company's revenue is primarily generated from its Karlawinda operations, amounting to A$632.01 million.
Estimated Discount To Fair Value:48.1%
Capricorn Metals is trading at A$13.36, significantly below its estimated future cash flow value of A$25.73, making it highly undervalued based on discounted cash flow analysis. The company's earnings are expected to grow at 28.35% annually over the next three years, outpacing both its revenue growth of 26% and the broader Australian market's growth rates. Additionally, Capricorn's Return on Equity is forecasted to reach a robust 28.9%.
Integral Diagnostics
Overview:Integral Diagnostics Limited is a healthcare services company offering diagnostic imaging services to medical professionals and their patients in Australia and New Zealand, with a market cap of A$771.05 million.
Operations:The company generates revenue of A$767.82 million from operating diagnostic imaging facilities across Australia and New Zealand.
Estimated Discount To Fair Value:49.9%
Integral Diagnostics is trading at A$2.07, well below its estimated future cash flow value of A$4.13, indicating significant undervaluation based on discounted cash flow analysis. Despite a dividend yield of 3.53% not being covered by earnings or free cash flows, the company's earnings are projected to grow at 32.6% annually over the next three years, surpassing both its revenue growth rate of 6.5% and broader market expectations for profit expansion in Australia.
Nuix
Overview:Nuix Limited offers investigative analytics and intelligence software solutions across the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market cap of A$469.17 million.
Operations:The company's revenue is primarily derived from its Software & Programming segment, which generated A$237.49 million.
Estimated Discount To Fair Value:45%
Nuix, currently priced at A$1.39, is trading significantly below its estimated future cash flow value of A$2.52, highlighting its undervaluation based on discounted cash flow analysis. The company has recently become profitable and is expected to see earnings grow by 38.2% annually over the next three years, outpacing the broader Australian market's growth rate of 12.1%. However, future return on equity remains low at a forecasted 8.6%, with high-quality earnings impacted by large one-off items.
-
The analysis detailed in our Nuix growth report hints at robust future financial performance.
-
Dive into the specifics of Nuix here with our thorough financial health report.
Where To Now?
-
Take a closer look at our Undervalued ASX Stocks Based On Cash Flows list of 42 companies by clicking here.
-
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
-
Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Seeking Other Investments?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:CMM ASX:IDX and ASX:NXL.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
